Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_assertion type Assertion NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_head.
- NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_assertion description "[ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_provenance.
- NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_assertion evidence source_evidence_literature NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_provenance.
- NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_assertion SIO_000772 11205461 NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_provenance.
- NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_assertion wasDerivedFrom befree-2016 NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_provenance.
- NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_assertion wasGeneratedBy ECO_0000203 NP308389.RANSLc0mrrFZVRpX_yaYUo1RJYDerX7kEBmr8rA98oMtQ130_provenance.